
User Reviews \| Add Review \| Search Reviews	Drug Search

You have entered 0 Drug(s) and 0 Symptom(s)

Click Evaluate for a complete analysis of your drugs and symptoms

Yaz (drospirenone-ethinyl estradiol) - Cervical cancer

Side Effect Search

Underlined words or phrases provide helpful links to information in wikipedia.org and when moused over often give helpful definitions of the medical terms. Keywords

Yaz may cause cervical cancer.

Medical Source Information
Yellow highlights indicate symptoms related to cervical cancer.

Oncologic side effects related to oral contraceptive use have been studied extensively. A number of studies have examined a possible relationship between the use of oral contraceptives and the development of breast cancer. Many of the studies have reported conflicting results. A committee of the World Health Organization evaluated these studies and the risks of breast cancer and concluded that: "Numerous studies have found no overall association between oral contraceptive use and risk of breast cancer." In addition, the same committee also examined a possible relationship between oral contraceptive use and neoplasms of the uterine cervix and concluded that: "There are insufficient data to draw any firm conclusions regarding the effects of combined oral contraceptives on the risk of cervical adenocarcinoma".

The World Health Organization committee also noted that some studies "have found a weak association between long-term use of oral contraceptives and breast cancer diagnosed before the age of 36, and perhaps up to the age 45....It is unclear whether this observed association is attributable to bias, the development of new cases of cancer, or accelerated growth of existing cancers." The World Health Organization committee further concluded that there is no increased risk of breast cancer in women over the age of 45 who have previously taken oral contraceptives. In addition, studies suggest that use of oral contraceptives does not place specific groups of women (like those with a family history of breast cancer) at higher or lower risk, and variations in the hormonal content of oral contraceptives do not influence the risk of breast cancer. In general, studies evaluating the potential risk of cervical cancer in patients taking oral contraceptives have been complicated by the large number of confounding factors which make investigations into the epidemiology of this neoplasm difficult. Some studies have suggested that women taking oral contraceptives are at increased risk of dysplasia, epidermoid carcinoma, and adenocarcinoma of the cervix. However, other studies have not found such an association.

Side Effects to Watch
Watch closely for the following side effects and notify your physician immediately should any of these develop:

Abnormal bruising or signs of bleeding such as bleeding from the gums, nose, digestive tract, vagina (females), faintness, dizziness, loss of consciousness, or rash (signs of problems with blood clot formation)

Lab and Diagnostic Tests
If certain symptoms develop, ask your physician whether you need the following lab tests or other diagnostic tests (if you've not already had them):

Monitor estradiol, glucose and potassium
Blood tests to assess normal clotting - in people who develop signs of bleeding such as abnormal bruising or signs of bleeding including bleeding from the gums, nose, digestive tract, vagina (females), faintness, dizziness, loss of consciousness, or rash

References

Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. Olsson H, Moller TR, Ranstam J J Natl Cancer Inst 1989;81:1000-4.
Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Tao LC Cancer 1991;68:341-7.
The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA Am J Obstet Gynecol 1992;166:1950-4.
Prospective study of oral contraceptive use and risk of breast cancer in women. Romieu I, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE J Natl Cancer Inst 1989;81:1313-21.
Oral contraceptives and cervical neoplasia. Brinton LA Contraception 1991;43:581-95.
Oral contraceptive use and liver cancer. Palmer JR, Rosenberg L, Kaufman DW, Warshauer ME, Stolley P, Shapiro S Am J Epidemiol 1989;130:878-82.
Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Jones MW, Silverberg SG Obstet Gynecol 1989;73:984-9.
The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer. Gross TP, Schlesselman JJ Obstet Gynecol 1994;83:419-24.
Oral contraceptives and breast cancer. A review with some comments on mathematical models. Lund E Acta Oncol 1992;31:183-6.
Choosing the best oral contraceptive. Stubblefield PG Clin Obstet Gynecol 1989;32:316-28.
Oral contraceptives and breast cancer: review of the epidemiologic literature. Thomas DB Contraception 1991;43:597-642.
Cancers related to contraceptive use. Rettig BA, Lemon HM Br J Cancer 1996;74:1509-10.
A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Hankinson SE, Colditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ Obstet Gynecol 1992;80:708-14.
Contraception. Mishell DR N Engl J Med 1989;320:777-85.
Benefits and risks of oral contraceptive use. Williams RS Postgrad Med 1992;92:155-7.
Oral contraceptives and cancer of the cervix uteri. A meta-analysis. Delgado-Rodriguez M, Sillero-Arenas M, Martin-Moreno JM, Galvez-Vargas R Acta Obstet Gynecol Scand 1992;71:368-76.
Female hormone utilisation and risk of hepatocellular carcinoma. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C Br J Cancer 1993;67:635-7.
Oral contraceptives: a reassessment. Derman R Obstet Gynecol Surv 1989;44:662-8.
Oral contraceptives and neoplasia. WHO Scientific Group. Anonymous World Health Organ Tech Rep Ser 1992;817:1-46.
Breast cancer and hormonal contraceptives: further results. Calle EE, Heath CW, Miraclemcmahill HL, Coates RJ, Liff JM, Franceschi S, Talamini R, Chantarakul N, Koetsawang S, Rachawat D Contraception 1996;54 (suppl:s1-106.
Oral contraceptive use and incidence of cervical intraepithelial neoplasia. Turnquest MA Am J Obstet Gynecol 1993;168:1895-6.
Association of focal nodular hyperplasia and hepatic hemangioma. Mathieu D, Zafrani ES, Anglade MC, Dhumeaux D Gastroenterology 1989;97:154-7.
Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Gyorffy EJ, Bredfeldt JE, Black WC Ann Intern Med 1989;110:489-90.
Oral contraceptives and gynecologic cancer: an update for the 1990s. Kaunitz AM Am J Obstet Gynecol 1992;167:1171-6.
Oral contraceptives and breast cancer: a cooperative italian study. Lavecchia C, Negri E, Franceschi S, Talamini R, Amadori D, Filiberti R, Conti E, Montella M, Veronesi A, Parazzini F, Ferraroni M Int J Cancer 1995;60:163-7.
Oral contraceptives and breast cancer. Schlesselman JJ Am J Obstet Gynecol 1990;163:1379-87.
Long-term health risks and benefits of oral contraceptive use. Peterson HB, Lee NC Obstet Gynecol Clin North Am 1990;17:775-88.
Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D Obstet Gynecol 1994;83:679-85.
Oral contraceptive use in women with a family history of breast cancer. Murray PP, Stadel BV, Schlesselman JJ Obstet Gynecol 1989;73:977-83.
A case-control study of the risk of breast cancer in relation to oral contraceptive use. Rosenberg L, Palmer JR, Clarke EA, Shapiro S Am J Epidemiol 1992;136:1437-44.
Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. John EM, Whittemore AS, Harris R, Itnyre J J Natl Cancer Inst 1993;85:142-7.
Oral contraceptives and breast cancer risk in Denmark. Ewertz M Eur J Cancer 1992;28A:1176-81.
Patterns of research. Oral contraceptives and cervical cancer. Sillero-Arenas M, Rodriguez-Contreras R, Delgado-Rodriguez M, Bueno-Cavanillas A, Galvez-Vargas R Acta Obstet Gynecol Scand 1991;70:143-8.
Oral contraception: risks and benefits. Steinberg WM Adv Contracept 1989;5:219-28.
Oral contraceptives and cervical cancer - further findings from the oxford family planning association contraceptive study. Zondervan KT, Carpenter LM, Painter R, Vessey MP Br J Cancer 1996;73:1291-7.
Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Colditz GA Ann Intern Med 1994;120:821-6.
Breast cancer before age 45 and oral contraceptive use: new findings. Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S Am J Epidemiol 1989;129:269-80.
Hepatic adenoma presenting as a right lower quadrant mass. Mooney MJ, Nyreen MR, Hall RA, Carter PL Am Surg 1993;59:229-31.
Benefits and risk of oral contraceptives. A reassessment. Burkman RT Jr J Reprod Med 1991;36:217-8.
Product Information. Yasmin (drospirenone-ethinyl estradiol) Anonymous Berlex Laboratories, Richmond, CA. PROD;

Multum version: 146.0 (Oct 22, 2009)

Add a User Review

To add a User Review fill out the fields below. A drug name is required to post. You will be asked to enter the dosage, which is listed on the bottle/container, along with units such as mg, ounces, etc; as well as how often you take the drug. When you enter a possible side effect, you will be asked about its severity. In the comment field, please describe your experiences or any comment that you will think help other users understand what they can expect from their drug treatment. We also welcome comments and suggestions about our site through feedback.

* Enter drug name- enter one drug at a time, by typing at least 3 letters of the drug name and select the appropriate drug from the list, then proceed to entering the next drug. Google

* Enter condition name - the "condition" is the reason you are taking the drug, which could be a disease such as "diabetes" or a symptom such as "joint aches". Enter a condition and select from the list shown, then enter the next condition if you are experiencing more than one.

* Enter side effects - these are any undesirable effects you might be experiencing from the drug(s). Enter your side effect and select from the list shown, then enter the next side effect if you are experiencing more than one. If you are not experiencing any side effects check the box below, No Side Effects.

No Side Effects

Enter comments - tell the community about your experiences and any information you may have about taking these drugs.

Age Gender:

Thank you for adding your review.

Return to Current Page

To help protect against automated posting, please enter the words that appear in the box below (more info).
Words should be separated by space.

Unable to see the image? (get another image)

* Required fields

NOTE: Just because a drug or combination of drugs can cause a symptom does not mean it is actually causing your symptom. Symptoms can be caused by medical conditions as well. Make sure that your physician is aware of any symptoms you are experiencing so he/she can work with you to determine the cause. Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: Please note that the information DoubleCheckMD.com provides is intended to help individuals to work with their medical professionals and is for educational purposes only. It does not constitute medical or healthcare advice and serves to supplement, not substitute for, the expertise and judgment of a healthcare professional. In all cases individuals should consult with a physician before taking any action based on DoubleCheckMD feedback including, but not limited to ceasing taking any drug, changing diet or commencing or discontinuing any course of treatment. The information provided by DoubleCheckMD.com is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that the use of a particular drug is safe, appropriate or effective.